Status:
COMPLETED
Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
12+ years
Brief Summary
The purpose of this study is to determine the incidence of misuse, i.e., over-use and under-use, of Budesonide/formoterol for maintenance and reliever therapy in usual-care setting.
Eligibility Criteria
Inclusion
- Established persistent asthma
- Currently treated with Symbicort SMART for 3 months or longer
Exclusion
- currently participating or have participated in a study with an investigational compound within the last 30 days
- current diagnosis of chronic obstructive pulmonary disease (COPD)
- smoked more than 10 pack-year
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2009
Estimated Enrollment :
1020 Patients enrolled
Trial Details
Trial ID
NCT00800241
Start Date
May 1 2009
End Date
November 1 2009
Last Update
December 3 2010
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Buriram, Thailand
2
Research Site
Chanthaburi, Thailand
3
Research Site
Chiang Mai, Thailand
4
Research Site
Mahasarakham, Thailand